Log In
Print
BCIQ
Print
Print this Print this
 

Orbactiv, oritavancin (formerly LY333328)

  Manage Alerts
Collapse Summary General Information
Company The Medicines Co.
DescriptionSemi-synthetic lipoglycopeptide antibiotic
Molecular Target
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today